These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19636335)

  • 1. Fracture prevention in men.
    Geusens P; Sambrook P; Lems W
    Nat Rev Rheumatol; 2009 Sep; 5(9):497-504. PubMed ID: 19636335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
    Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
    Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis.
    Compston JE; McClung MR; Leslie WD
    Lancet; 2019 Jan; 393(10169):364-376. PubMed ID: 30696576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating osteoporosis to prevent fractures: current concepts and future developments.
    Lorentzon M
    J Intern Med; 2019 Apr; 285(4):381-394. PubMed ID: 30657216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.
    Bouxsein ML; Chen P; Glass EV; Kallmes DF; Delmas PD; Mitlak BH
    J Bone Joint Surg Am; 2009 Jun; 91(6):1329-38. PubMed ID: 19487509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
    Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A;
    Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis in men and women.
    Bonnick SL
    Clin Cornerstone; 2006; 8(1):28-39. PubMed ID: 17591574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios].
    Di Munno O; Delle Sedie A
    Reumatismo; 2011; 63(2):67-79. PubMed ID: 21776442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of osteoporosis medications on bone quality.
    Benhamou CL
    Joint Bone Spine; 2007 Jan; 74(1):39-47. PubMed ID: 17196423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Degenerative osteoarthritis, osteoporosis and fractures: controversies and evidences].
    Pagès-Castellà A; Prieto Alhambra D
    Med Clin (Barc); 2013 Sep; 141(5):217-20. PubMed ID: 23540390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of teriparatide in osteoporotic fracture patients.
    Collinge C; Favela J
    Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Men with osteoporosis: are they being treated fairly?
    Legrand E
    Joint Bone Spine; 2001 May; 68(3):191-3. PubMed ID: 11394617
    [No Abstract]   [Full Text] [Related]  

  • 14. 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture.
    Seeman E; Eisman JA
    Med J Aust; 2004 Mar; 180(6):298-303. PubMed ID: 15012571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy.
    Kaufman JM; Orwoll E; Goemaere S; San Martin J; Hossain A; Dalsky GP; Lindsay R; Mitlak BH
    Osteoporos Int; 2005 May; 16(5):510-6. PubMed ID: 15322742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of glucocorticoid induced osteoporosis].
    Arazzi M; Di Fulvio G; Di Pietro LO; Grabocka X; Longo MO; Micioni G; Pezzutto A; Piscitani L; Schiazza A; Silvestri S; Vigilante G; Amoroso L; Bonomini M
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Once-weekly teriparatide treatment on osteoporosis].
    Nakano T
    Clin Calcium; 2014 Jan; 24(1):100-5. PubMed ID: 24369286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications to teriparatide treatment in patients with osteoporosis.
    Rizzoli R; Kraenzlin M; Krieg MA; Mellinghoff HU; Lamy O; Lippuner K
    Swiss Med Wkly; 2011; 141():w13297. PubMed ID: 22057669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premenopausal Osteoporosis.
    Cohen A
    Endocrinol Metab Clin North Am; 2017 Mar; 46(1):117-133. PubMed ID: 28131128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teriparatide in the treatment of osteoporosis.
    Stroup J; Kane MP; Abu-Baker AM
    Am J Health Syst Pharm; 2008 Mar; 65(6):532-9. PubMed ID: 18319498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.